Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Gemcitabine × Classical hematology × Clear all

Phase

Status

Completed 4 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 69 Genitourinary 34 Thoracic 22 Breast 18 Head & Neck 13 Lymphoid 12 Gynecologic 12 Sarcoma 4 Other solid neoplasm 3 Dermatologic 3 CNS 3 Other hematologic neoplasm 2 Classical hematology 1

Conditions

Interventions

Cyclophosphamide 8 Whole-Body Irradiation 7 fludarabine 5 Mycophenolic Acid 5 fludarabine phosphate 4 Tacrolimus 4 Melphalan 4 Busulfan 4 Peripheral Blood Stem Cell Transplantation 3 Azacitidine 3 Vorinostat 2 Thiotepa 2 Sirolimus 2 Lenalidomide 2 Granulocyte Colony-Stimulating Factor 2 Etoposide 2 Cyclosporine 2 Biopsy 2 Ascorbic Acid 2 AP 1903 reagent 2 venetoclax 1 ribociclib 1 palbociclib 1 olaparib 1 luspatercept 1 ibrutinib 1 edoxaban 1 decitabine and cedazuridine drug combination 1 cc-486 1 apixaban 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06018883 2025-08-07

PTCA199-3

Fudan University

Phase 3 Active not recruiting

Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡